BiotechTubeBiotechTube
Home/Character Biosciences/Peter DiLaura
PD

Peter DiLaura

Board Member (Independent)

Character Biosciences

Therapeutic Areas

OphthalmologyRetinal DiseasesNeurodegenerative Diseases

Character Biosciences Pipeline

DrugIndicationPhase
CTX203High risk intermediate AMD (dry AMD)Phase 1
CTX114Geographic Atrophy (secondary to AMD)Phase 1
Undisclosed AMD ProgramAge-Related Macular Degeneration (AMD)Research
Undisclosed POAG ProgramPrimary Open-Angle Glaucoma (POAG)Research

Leadership Team at Character Biosciences

CZ
Cheng Zhang
CEO, Co-Founder
LC
Laura Carter, PhD
Chief Scientific Officer
RK
Robert Kim, MD, MBA
Chief Medical Officer
DE
Daniel Elgort, PhD
Chief Data and Analytics Officer
EK
Erik Karrer, PhD
SVP, Drug Discovery
KS
Kaila Smilen, MBA
Senior Director, BD & Corporate Strategy
DC
Dinah Chen, MD
Medical Director and Clinical Innovation Lead
JG
Jonathan Gumucio, PhD
Director, Drug Discovery
MC
May Chen, PhD
Director, Drug Discovery
JB
Josh Buddle
Head of Clinical Network and Longitudinal Research
View full Character Biosciences profile